Numeric, an AI-driven accounting automation platform, has raised $51m in a Series B funding round spearheaded by IVP. The round also saw contributions from Access Industries, Alkeon, Founders Fund, Long Journey Ventures, Menlo Ventures, Socii Capital and 8VC, plus, Friends & Family Capital and Fifth Down. Additionally BlackLine former CEO Marc Huffman and NetSuite former CFO Ron Gill participated in the round. This latest funding brings Numeric’s total raised capital to $89m and will enable the company ...

Repligen Conference Call Summary Company Overview - **Company**: Repligen (NasdaqGS:RGEN) - **Date**: November 11, 2025 - **Key Performance**: Achieved 18% organic growth in Q3, with all key product areas showing double-digit growth [1][2] Core Insights Financial Performance - **Q3 Results**: Non-COVID organic growth of 16% year-to-date [2] - **Operating Margins**: 14.2%, a decrease of 70 basis points [1] - **Earnings Beat**: Exceeded market expectations by $0.05 on the bottom line [1] Product Portfolio and Market Segments - **Diverse Portfolio**: Emphasized the broad and innovative product range, with analytics and protein franchises outperforming expectations [3] - **Market Recovery**: Notable recovery in biopharma and CDMO sectors, with small biotech showing a significant rebound in sales and orders [4] - **Emerging Biotech**: Defined as biotech companies without commercial products; funding increased to approximately $12 billion in Q3, up from $8.9 billion in Q2 [6] Geographic Insights - **China Market**: Primarily driven by established pharma companies rather than emerging biotech; order intake slowed due to inventory buildup [8][54] Growth Projections - **Filtration Outlook**: Expected growth of 10-12%, with a focus on fluid management and delays in order deliveries affecting projections [12][15] - **Chrome Segment**: Experienced significant growth due to successful conversions of big pharma customers [18] - **Protein Segment**: Transitioned to a more autonomous business model, with expectations for double-digit growth driven by custom and catalog resins [21][25] New Modalities and Future Opportunities - **New Modalities**: Positive outlook for new modalities, including cell therapy and antibody-drug conjugates, with a diversified portfolio mitigating risks from specific programs [28][29] - **Cell Therapy**: Strong demand anticipated, particularly for ATF technology, with plans to expand product offerings [32] Operational and Margin Considerations - **Operational Expenses**: Organic OpEx growth of 14%, with a target to align OpEx growth with top-line growth in the coming years [48][49] - **Margin Goals**: Aiming for 30% EBITDA by 2030 and mid-50s gross margin in the next few years [51][52] Strategic Initiatives - **Onshoring Trends**: Anticipated RFPs related to onshoring expected to emerge by mid-2026, presenting significant opportunities for bioprocessing companies [38][39] - **Hardware Growth**: Hardware revenue increased by 20%, with expectations for continued growth driven by differentiated product offerings [42] Conclusion - **Market Positioning**: Repligen aims to maintain a growth rate of 5% above market growth, leveraging its innovative portfolio and clinical exposure to drive demand [57][58]

Core Insights - Altus Group Limited reported steady growth in recurring revenue and an expansion in adjusted EBITDA margin for Q3 2025, indicating a positive financial trajectory [1][2]. Financial Performance - Revenue for Q3 2025 reached C$133.3 million, a 2.2% increase from C$128.4 million in Q3 2024 [2]. - Recurring revenue grew by 5.2% to C$102.4 million compared to C$95.4 million in the same quarter last year [2]. - Profit from continuing operations improved significantly to C$0.5 million from a loss of C$2.9 million, marking a 117.8% change [2]. - Adjusted EBITDA increased by 16.1% to C$25.6 million, with an adjusted EBITDA margin of 19.2%, up 230 basis points from 16.8% [2]. - Free cash flow rose by 36.5% to C$21.9 million, with free cash flow per share increasing by 45.7% to C$0.51 [2]. Business Outlook - The company provided guidance for Q4 2025, projecting 3-5% growth in total analytics revenue and 5-7% growth in recurring revenue [5]. - Adjusted EBITDA margin expansion is expected to be between 200-300 basis points for Q4 2025 [5]. - The full-year outlook for 2025 has been refined, now anticipating 2-4% growth in total analytics revenue and 4-6% growth in recurring revenue [5][6]. Dividend Information - The Board approved a cash dividend of C$0.15 per common share for Q4 2025, payable on January 15, 2026 [8]. Cash Flow and Financial Health - Net cash provided by operating activities for Q3 2025 was C$22.6 million, a 22.8% increase from C$18.4 million in Q3 2024 [2]. - The funded debt to EBITDA ratio improved to 1.21 from 2.07, indicating a stronger balance sheet [2]. Shareholder Information - The company’s Dividend Reinvestment Plan (DRIP) allows eligible shareholders to reinvest dividends into additional common shares at a discount [9]. Company Overview - Altus Group Limited specializes in providing commercial real estate intelligence, leveraging data and analytics to enhance performance and mitigate risks in the industry [12].

Core Viewpoint - Booz Allen Hamilton Holding Corporation (BAH) reported weak financial results for Q2 of fiscal 2026, leading to multiple analysts reducing their price targets for the stock [2][5]. Financial Performance - Revenue decreased by 8.1% year-over-year to $2.9 billion, while net income fell by 55.1% to $175 million compared to the same period last year [2]. - The company has revised its full-year outlook downward due to a "continued funding slowdown" [2]. Analyst Reactions - Stifel reduced its price target from $119 to $106 while maintaining a Hold rating, noting this was the second time in three months that management's outlook was worse than expected [3]. - Goldman Sachs lowered its price target from $93 to $80 and kept a Sell rating, citing weak financial performance and adverse effects from government funding re-prioritization [5]. - UBS also cut its price target from $115 to $93, maintaining a Neutral rating on the stock [6]. Market Environment - Analysts indicated that while the market environment for government services is not worsening, it remains far from normalizing for Booz Allen [4]. - There is ongoing volatility and uncertainty in the market, prompting analysts to favor stocks that are not experiencing similar declines [4][6].

Moving the world of Commerce forward October 2025 Forward-Looking Statements and Non-GAAP Financial Measures *Source: TAM Analysis and Market Penetration Study leveraging US Census NAICS Codes across Retail (42 Wholesalers), Distribution (42 Wholesalers), CPG/Finished Goods (31-33 Manufacturing), Retailers/Stores acting as suppliers (44-45 Retail Trade) as of February 2025. This presentation contains forward-looking statements, including information about management's view of SPS Commerce's future expectati ...

Third Quarter 2025 Earnings Presentation October 28, 2025 © 2025 MSCI Inc. All rights reserved. Introduction → Forward-Looking Statements 3 → Foreign currency exchange rate fluctuations reflect the difference between the current period results as reported compared to the current period results recalculated using the foreign currency exchange rates in effect for the comparable prior period. While operating revenues adjusted for the impact of foreign currency fluctuations includes asset-based fees that have b ...

Core Insights - MSCI reported strong financial performance for Q3 2025, with record recurring sales in its Index and Analytics product lines, and a significant increase in asset-based fees driven by growth in assets under management (AUM) [3][4][6] Financial Highlights - Operating revenues reached $793.4 million, a 9.5% increase year-over-year, with organic operating revenue growth of 9.0% [4][6] - Operating income was $447.7 million, up 11.6%, resulting in an operating margin of 56.4% [4][9] - Net income increased by 15.8% to $325.4 million, with diluted EPS rising 19.0% to $4.25 [4][11] - Adjusted EBITDA was $494.4 million, reflecting a 9.7% increase, with an adjusted EBITDA margin of 62.3% [4][12] Revenue Breakdown - Recurring subscription revenues grew by 7.9%, while asset-based fees surged by 17.1% [4][6] - The Index segment saw operating revenues of $451.2 million, an 11.4% increase, driven by higher asset-based fees and recurring subscription revenues [14][15] - The Analytics segment reported operating revenues of $182.2 million, up 5.7%, primarily from recurring subscriptions [17][18] - Sustainability and Climate segment revenues increased by 7.7% to $90.1 million, driven by growth in recurring subscriptions [20][21] Client Metrics - The total Run Rate as of September 30, 2025, was $3,186.5 million, up 10.1%, with a retention rate of 94.7% [7][4] - Organic recurring subscription Run Rate growth was 7.4% [7] Capital Allocation - MSCI repurchased $1,248.9 million worth of shares, with an average repurchase price of $559.95 [4][28] - Approximately $137.4 million in dividends were paid to shareholders, with a cash dividend of $1.80 per share declared for Q4 2025 [4][29] Guidance - MSCI provided guidance for Full-Year 2025, projecting operating expenses between $1,415 million and $1,445 million, and net cash provided by operating activities between $1,540 million and $1,590 million [31][30]

Core Points - Nasdaq, Inc. has declared a quarterly dividend of $0.27 per share on its outstanding common stock, payable on December 19, 2025, to shareholders of record as of December 5, 2025 [1] Company Overview - Nasdaq is a leading global technology company that serves corporate clients, investment managers, banks, brokers, and exchange operators, facilitating their interaction with global capital markets [2] - The company aims to deliver world-leading platforms that enhance liquidity, transparency, and integrity within the global economy [2] - Nasdaq offers a diverse range of data, analytics, software, exchange capabilities, and client-centric services to help clients optimize and execute their business strategies [2]

Procore Helix & AI - Procore Helix is a construction intelligence layer comprised of AI, analytics, and agentic workflows, designed for decision confidence [20] - Procore is developing Agents, digital teammates embedded across the platform, to streamline workflows and automate tasks [22] - Over 2,000 customers are using Assist, with over 14,000 monthly active Assist users [31, 32] - Developer Studio, Procore's integration platform, will connect thousands of systems to orchestrate transactional workflows, evolving to AI-driven automation [25] Platform Innovation - Procore's investments in the platform have accelerated the pace of innovation, with over 400 features launched since Groundbreak '24 [16] - Procore has resolved over 20,000 UserVoice votes, doubling the prior year's resolution rate [16] - Scheduling 2.0 and Resource Management are now available [49, 55] Owner Opportunity - Owners represent 25% of Procore's Total ARR [38] - Procore has over 3,200 owner customers [38] - Procore has approximately 3% penetration within its addressable market of owners, representing roughly 100,000 global owners in active GTM countries [38]

Core Insights - Virtu Financial, Inc. will announce its third quarter 2025 financial results on October 29, 2025, before the US market opens [1] - A conference call to discuss the financial results will take place at 8:00 AM (EDT) and will be accessible to the public via a live webcast [2] Company Overview - Virtu Financial is a leading provider of financial services and products, utilizing advanced technology to deliver liquidity and innovative trading solutions to clients [3] - The company offers a comprehensive product suite that includes execution, liquidity sourcing, analytics, and broker-neutral, multi-dealer platforms across various asset classes [3] - Virtu operates in over 50 countries, allowing clients to trade on hundreds of venues in global equities, ETFs, foreign exchange, futures, fixed income, cryptocurrency, and other commodities [3] - The integrated, multi-asset analytics platform provides pre-, intra-, and post-trade services, data products, and compliance tools for clients to manage risk and invest across global markets [3]